GlassScriptPhysician profile
Frank D Rosenbaum
NPI 1598783623
$2,056.66
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,299 · 2020: $541 · 2021: $180 · 2022: $37.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $596.17 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $282.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $254.45 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $222.88 | 2019-2020 | |
| Ivantis, INC | $162.30 | 2019 | |
| Mallinckrodt Hospital Products INC. | $91.71 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $90.75 | 2020-2021 | |
| Alcon Vision LLC | $56.91 | 2019-2022 | |
| Shire North American Group INC | $53.79 | 2019 | |
| Allergan, INC. | $45.44 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $37.45 | 2019-2021 | |
| Coopervision INC. | $34.17 | 2019 | |
| Carl Zeiss Meditec, INC. | $31.60 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.80 | 2020-2021 | |
| New World Medical,INC. | $15.56 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $15.47 | 2020 | |
| Ocular Therapeutix, INC. | $14.24 | 2021 | |
| Dompe US, INC. | $13.85 | 2019 | |
| Eyepoint US, INC. | $12.52 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.